Citigroup’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-75,900
Closed -$1.13M 5790
2023
Q4
$1.13M Hold
75,900
﹤0.01% 2718
2023
Q3
$1.23M Hold
75,900
﹤0.01% 2347
2023
Q2
$3.15M Buy
75,900
+69,500
+1,086% +$4.32M ﹤0.01% 1821
2023
Q1
$385K Sell
6,400
-150,000
-96% -$12M ﹤0.01% 3311
2022
Q4
$11.5M Sell
156,400
-43,600
-22% -$3.28M 0.01% 1060
2022
Q3
$15.2M Buy
200,000
+50,000
+33% +$3.9M 0.01% 928
2022
Q2
$10.4M Hold
150,000
0.01% 1137
2022
Q1
$12.4M Sell
150,000
-230,000
-61% -$16.9M 0.01% 1183
2021
Q4
$28.5M Buy
380,000
+5,000
+1% +$502K 0.02% 831
2021
Q3
$43.6M Buy
375,000
+25,000
+7% +$3.78M 0.03% 593
2021
Q2
$77.6M Buy
+350,000
New +$68.1M 0.05% 373
2017
Q4
Sell
-11,500
Closed -$228K 7620
2017
Q3
$228K Buy
+11,500
New +$226K ﹤0.01% 4883

Other funds holding NVCR